December 26, 2016
Japanese generic major Sawai Pharmaceutical said on December 22 that it has won a patent infringement suit filed by Swiss-based Debiopharm International SA over the anticancer agent Elplat (oxaliplatin). In the suit, the Swiss drug maker claimed that generic versions...read more